Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Alnylam Pharmaceuticals Inc (ALNY)  
$143.95 3.41 (2.31%) as of 4:30 Tue 4/30


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 123,030,000
Market Cap: 17.71(B)
Last Volume: 477,045 Avg Vol: 726,924
52 Week Range: $143.71 - $212.05
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  824
Guru Rank Value     : 0.5
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company developing therapeutics based on RNA interference. Co. has four RNAi-based medicines, ONPATTRO® (patisiran), GIVLAARI® (givosiran), OXLUMO™ (lumasiran) and Leqvio® (inclisiran). ONPATTRO is approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. GIVLAARI is approved for the treatment of adults with acute hepatic porphyria. Co. has approval for OXLUMO for the treatment of hyperoxaluria type 1 (PH1) in all age groups. Leqvio (inclisiran) is being developed for the treatment of adults with hypercholesterolemia or mixed dyslipidemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 46,855 76,855 102,504 247,093
Total Sell Value $7,107,715 $12,957,715 $17,713,340 $48,829,179
Total People Sold 6 7 8 9
Total Sell Transactions 11 12 18 35
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 475
  Page 4 of 19  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Garg Pushkal CMO & EVP Dev & Med Affairs   •       –      –    2022-08-04 4 D $189.76 $974,201 D/D (5,086) 17,417     -
   Vaishnaw Akshay President   •       –      –    2022-08-04 4 D $189.76 $1,160,335 D/D (6,052) 18,346     -
   Poulton Jeffrey V. EVP, Chief Financial Officer   •       –      –    2022-08-04 4 D $189.76 $968,824 D/D (5,054) 9,406     -
   Tanguler Tolga EVP, Chief Commercial Officer   •       –      –    2022-08-04 4 D $189.76 $342,817 D/D (1,788) 1,841     -
   Greenstreet Yvonne Chief Executive Officer   •       •      –    2022-08-04 4 D $189.76 $1,150,439 D/D (6,002) 20,995     -
   Garg Pushkal CMO & EVP Dev & Med Affairs   •       –      –    2022-08-03 4 A $0.00 $0 D/D 11,311 22,503     -
   Vaishnaw Akshay President   •       –      –    2022-08-03 4 A $0.00 $0 D/D 13,183 24,398     -
   Poulton Jeffrey V. EVP, Chief Financial Officer   •       –      –    2022-08-03 4 A $0.00 $0 D/D 11,325 14,460     -
   Tanguler Tolga EVP, Chief Commercial Officer   •       –      –    2022-08-03 4 AS $210.00 $368,340 D/D (1,754) 3,629 10%     
   Tanguler Tolga EVP, Chief Commercial Officer   •       –      –    2022-08-03 4 A $0.00 $0 D/D 3,629 5,383     -
   Greenstreet Yvonne Chief Executive Officer   •       •      –    2022-08-03 4 A $0.00 $0 D/D 13,095 26,997     -
   Tanguler Tolga EVP, Chief Commercial Officer   •       –      –    2022-07-05 4 AS $150.00 $263,100 D/D (1,754) 1,754 44%     
   Paul Steven M Director   –       •      –    2022-04-01 4 AS $166.04 $2,560,371 D/D (15,000) 1,000 36%     
   Paul Steven M Director   –       •      –    2022-04-01 4 OE $11.33 $169,950 D/D 15,000 16,000     -
   Sharp Philip A Director   –       •      –    2022-02-09 4 AS $150.00 $4,500,000 D/D (30,000) 0 -8%     
   Sharp Philip A Director   –       •      –    2022-02-09 4 OE $11.33 $339,900 D/D 30,000 30,000     -
   Tanguler Tolga EVP, Chief Commercial Officer   •       –      –    2022-02-02 4 D $144.67 $219,609 D/D (1,518) 3,508     -
   Tanguler Tolga EVP, Chief Commercial Officer   •       –      –    2022-02-01 4 OE $0.00 $0 D/D 5,026 5,026     -
   Garg Pushkal CMO & EVP Dev & Med AffairsOff   •       –      –    2021-12-31 3 IO $0.00 $0 I/I 0 681 -29%     
   Garg Pushkal CMO & EVP Dev & Med AffairsOff   •       –      –    2021-12-31 3 IO $0.00 $0 D/D 0 11,192 -29%     
   Vaishnaw Akshay President, R&D   •       –      –    2021-12-23 4 AS $186.22 $549,698 D/D (2,879) 11,215 -26%     
   Vaishnaw Akshay President, R&D   •       –      –    2021-12-22 4 D $186.48 $479,690 D/D (2,538) 14,094     -
   Maraganore John Chief Executive Officer   •       •      –    2021-12-22 4 D $186.02 $1,254,077 D/D (6,636) 227,663     -
   Greenstreet Yvonne President & COO   •       –      –    2021-12-22 4 D $186.55 $479,699 D/D (2,538) 13,902     -
   Vaishnaw Akshay President, R&D   •       –      –    2021-12-21 4 A $0.00 $0 D/D 5,417 16,632     -
  475 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 4 of 19
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us